Articles tagged with Cancer Genomics
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found that high blood sugar levels in diabetes can cause DNA damage and reduce its repair, increasing the risk of certain cancers. The study suggests that controlling blood sugar levels could be an effective way to reduce cancer risk in diabetics.
Researchers analyzed genomic data from 317 MCC patients and found two distinct populations with different genetic profiles and treatment responses. Immunotherapies showed high effectiveness in both groups, with better response rates when given early treatment.
Researchers explore new tools and strategies to interpret multiomics data, revealing insights into bacterial strains and cancer phenotypes.
The freely available data set includes unique comparisons of almost 1,000 cancer cell lines' responses to 453 licensed and experimental drugs. The dataset offers a rich resource for cancer scientists to discover more about how cancer cells work and generate new therapeutics and drug combinations.
University of Birmingham researchers found that the BRCA1 gene changes shape to protect vulnerable DNA until copying machinery can be restarted. This discovery could help understand how cancers develop and potentially identify new ways to suppress tumors.
A study by Massachusetts General Hospital found that DNA single strands can be highly sensitive to mutation by gene-editing enzymes. Many mutations occur in genes unrelated to cancer development, highlighting the need to distinguish between 'driver' and 'passenger' mutations.
A new study from the University of California, Irvine, reveals that many recurrent cancer mutations are not drivers of cancer progression but rather passenger hotspots. The research identified APOBEC3A as a key player in creating these hotspot mutations, which can be targeted for novel cancer therapies.
Researchers at Montana State University have developed software to analyze pangenomes, which can help identify genetic variations associated with drought tolerance in plants. The tool also shows promise for diagnosing diseases with a genetic component, such as certain types of cancer.
The study found that ARID1A controls the genome-wide positioning of condensin II, a complex regulating gene expression through organizing chromosome structure. This loss affects global gene expression, with broad consequences for cancer types, especially ovarian cancer.
Researchers analyzed over 3,500 tumor samples to identify genomic changes that inform targeted treatment strategies for men with advanced prostate cancers. The study found that more than half of patients have characteristics that suggest they are suitable for targeted therapies.
A computational tool assigns a bladder cancer subtype to an individual patient using genomic data, enabling personalized treatment selection. The study found that patients with the aggressive 'neuronal' subtype responded well to atezolizumab treatment, achieving high survival probabilities.
Researchers found that MSI intensity and mutational load significantly impact MMR-deficient tumors' response to PD-1 therapy. Higher mutational loads result in better responses to treatment.
Researchers have identified three medicinal plants from Mauritius with effective inhibitors of esophageal cancer cells, stopping their growth and contributing to their death. The extracts contain natural chemical compounds that restrain the G2/M stages transition in malignant tumor cells by activating AMPK signaling pathway.
Researchers at the Okinawa Institute of Science and Technology Graduate University have decoded the genome of the popular Japanese brown seaweed ito-mozuku. The study reveals genes that drive up fucoidan production, a substance with potential health benefits, and provides data that could aid in farming.
Genevera Allen, a Rice University statistician, emphasizes the need for machine learning systems to question their predictions and assess uncertainty. She argues that current ML techniques often rely on uncorroborated data-driven discoveries, leading to reproducibility issues in fields like precision medicine.
Researchers at University of California San Diego found evidence that p53 stimulates tumor growth by enhancing cancer metabolism, challenging the widely accepted idea that it suppresses cancer. The study suggests that drug therapies designed to enhance p53's function may inadvertently cause opposite effects.
Researchers discovered that EZH2 mutations disrupt chromatin organization, leading to increased tumor growth and altered gene expression. Inhibiting mutated EZH2 restores normal gene regulation, highlighting its therapeutic potential for cancer treatment.
A new study by Tel Aviv University researchers has identified a protein called ubiquilin-4 as a biomarker for genome instability. Elevated levels of this protein in tumor cells accelerate cancer progression and make them resistant to common treatments.
A unique nano-scaled DNA signature common to all cancers has been discovered, allowing for rapid detection from various tissues. This breakthrough technology uses gold nanoparticles to detect cancer DNA fragments and could lead to point-of-care diagnostics.
A new study has shown that genomic profiling can provide meaningful information for more than half of people with rare cancers, influencing diagnosis and treatment. The trial found that 20% of participants received a new treatment plan, and 6% were given a new diagnosis.
Researchers have discovered a possible path forward in preventing cancers linked to the Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV), which cause infectious mononucleosis. By blocking the viruses' defense proteins, it may be possible to treat mono and prevent cancer development.
Researchers developed a novel computational tool called ADmiRE to annotate human microRNA variants and determine their potential contribution to diseases. The tool successfully identified microRNA mutations in miR-142 and miR-21 linked to hematologic cancers and esophageal cancer, respectively.
Researchers discovered that cancer-causing papillomaviruses diverged from their common ancestors half a million years ago, coinciding with the split between Neanderthals and modern humans. The viruses adapted to specific host ecosystems and then coevolved with primates for at least 40 million years.
A new Northwestern Medicine study reveals a 'kill code' embedded in every cell that can trigger the self-destruction of cancerous cells. The toxic small RNA molecules can also be triggered by chemotherapy, offering a potential bulletproof treatment against cancer.
Scientists discovered millions of tumor-associated end coordinates in circulating DNA from hepatocellular carcinoma patients. This detection method could enhance the cost-effectiveness of liquid cancer biopsies by identifying cancer biomarkers more readily.
Researchers have mapped the chromatin accessibility landscape of 23 primary human cancer types using ATAC-seq, identifying over 500,000 active DNA regulatory elements. This comprehensive dataset may help partition cancer patients for more effective therapies.
A new DNA tool created by Michigan State University can accurately predict people's height and potentially assess their risk for serious illnesses like heart disease and cancer. The tool uses machine learning and analyzes the complete genetic makeup of nearly 500,000 adults in the UK to build predictors for complex traits.
A study of 50,000 people found that over 80% of those with identifiable genetic risk for breast, ovarian, prostate, and pancreatic cancer are unaware they carry the gene. The findings highlight the need for effective DNA-based screening to identify high-risk individuals before a cancer diagnosis.
A new study reveals how KSHV protein LANA drives chromosomal instability, promoting cell proliferation and aneuploidy. The findings identify NNLS as a promising target for antiviral therapies.
Researchers discovered 137 interactions between HPV proteins and human proteins, revealing common pathways with smoking-related cancers. The study highlights the importance of targeting specific proteins to develop effective treatments for HPV-positive head and neck cancers.
Researchers develop radiomic signature to predict efficacy of immunotherapy in patients with solid tumors. The algorithm analyzes CT scan images to extract biological information, providing a predictive score for treatment effectiveness.
Researchers identify TLK1 and TLK2 as critical for accurate DNA replication, preventing extensive damage and cell death. The study found that these enzymes are rarely mutated in cancers but their high expression correlates with poor patient outcomes.
At least 1% of the US population has an identifiable genetic risk for cancer or heart disease that can be detected through genomic screening. Implementing routine genomic screening could lead to significant benefits, but more work is needed to develop functioning models.
Researchers developed a new technology to identify microRNAs from non-culturable pathogens, discovering five highly probable papillomavirus-encoded microRNAs. These microRNAs regulate viral gene expression and control the papillomavirus life cycle.
Mary-Claire King has been recognized by ASHG for her tireless advocacy on using genetics to help people and families worldwide. Her lab has helped reunite 130 families through mtDNA sequencing, and her work with the UN Forensic Anthropology Team has identified victims of extra-judicial execution.
Researchers developed a method to detect genes under selection and found essential cancer genes and immune-exposed protein regions under significant negative selection. This challenges the exclusive role of positive selection in cancer evolution.
The American Society of Human Genetics (ASHG) recognizes Dr. Andrew Adey's contributions to cancer development and progression research. His novel single-cell technologies are being used worldwide to understand epigenetics and disease models.
Researchers found a cancerous tumor that has been present in modern American dogs for thousands of years, tracing it back to ancient dog populations that arrived with early humans. The study suggests catastrophic events may have led to the sudden disappearance of these early canines.
Scientists discovered that mitochondria and nuclear genomes co-evolved to independently cross-regulate each other. This understanding could lead to greater insights into aging and disease, as well as new treatments based on mitochondrial DNA.
Research reveals that ancient American dogs disappeared rapidly following the arrival of Europeans, leaving little genetic signature in modern American dogs. A close relative of these dogs lives on as a transmissible cancer, with its genome mirroring that of the original dog.
A new computational strategy using Bayesian analysis and CRISPR/Cas9 screening technology has identified 29 genetic changes contributing to rhabdomyosarcoma, a common childhood cancer. The study suggests potential treatments for the disease and provides a general approach for identifying oncogenic drivers in other cancers.
Researchers at Cincinnati Children's Hospital Medical Center found that a protein called AMPK drives aggressive and deadly brain cancers like glioblastoma. Blocking AMPK may produce therapeutic benefit for patients with few treatment options. Additional research is needed to translate the findings into patient care.
A collaborative effort has discovered molecular features of testicular germ cell cancers, identifying potential mutations and other molecular changes. The study found signs of duplicated DNA and defects in DNA methylation, which could inform future efforts to improve treatment decisions and help monitor patients for cancer recurrence.
Scientists at the University of Sheffield have discovered an enzyme called UCHL3 that regulates DNA repair and may hold promise in improving treatment for chemotherapy-resistant cancers. The findings also suggest a link between UCHL3 activity and brain ageing, which could impact memory, cognitive function, and learning.
Scientists discovered that altered cohesin SA2 variant influences gene expression and favours loss of differentiation in tumour cells. The two cohesin variants have distinct functions, with SA1 involved in topological domains and SA2 regulating gene expression through local chromatin loops.
Researchers identified four survival strategies in childhood cancer cells: tolerance, coexistence, competition, and chaos. These strategies are associated with varying outcomes, with increased risk of relapse seen in competition and chaos variants.
A research group has developed a new technique to study the behavior of p53 conformers, which are prone to forming amyloid aggregates that contribute to cancer development. The approach allows researchers to observe these conformers before they aggregate, providing potential tools for understanding and blocking their formation.
Scientists create cell models with specific DNA repair gene defects, allowing them to identify genomic scars associated with these defects. These scars can serve as biomarkers for molecular characterization of tumors and improve personalized cancer treatment.
Researchers used human and C. elegans data to understand the mutational causes of cancer, finding a resemblance between nematode worms and human cancer genomes. They discovered DNA mismatch repair deficiencies in both species, providing insights into the causes of cancer and potential treatment avenues.
Researchers have discovered five previously unknown cancer subtypes among others, using a comprehensive analysis of 2,579 tumors from breast and gynecologic cancers. The study identifies shared and unique molecular features, clinically significant subtypes, and potential therapeutic targets.
Researchers have developed a new classification system for cancer based on molecular characteristics, identifying 28 subtypes and improving treatment options. The new approach has the potential to revolutionize cancer diagnosis and patient care.
A groundbreaking cancer genomics study reveals new molecular classifications, enabling the re-classification of 33 tumor types into 28 distinct clusters. These findings hold promise for immune-based and other novel cancer therapeutics, as well as repurposing drugs used to treat other diseases.
Researchers analyzed genomic and molecular data from 33 cancer types and identified 28 molecular clusters. The study provides new insights into cancer classification and potential treatment options.
Researchers discovered that some cancers are genetically similar, despite originating from different organs, and grouped them into new subtypes. The study's findings support an additional cancer classification system, which could lead to improved treatment options for patients.
Researchers identified nearly 200 mutations in non-coding DNA that play a functional role in cancer, providing potential molecularly targeted therapeutics. These mutations could represent new targets for cancer drugs and may help explain the diversity of genetic mutations in tumors.
Research at Huntsman Cancer Institute found that estrogen and glucocorticoid receptors work together to promote more aggressive endometrial cancers. The study suggests that corticosteroids, a stress hormone, can make the uterine lining stop growing but may also contribute to tumor growth when combined with high estrogen levels.
Scientists successfully use ultrasound to propel gold nanowires carrying the Cas9-sgRNA complex across cell membranes, enabling targeted gene knockout. The system is simple and requires minimal payload, making it a promising therapeutic approach for cancer treatment.
A team of computer scientists has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient's genetic markers. eGARD, the first publicly available system of its kind, can match genetic signatures with outcomes with 95 percent precision.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have made a groundbreaking discovery that may advance neural stem cell treatments for brain disorders. The study reveals how an mRNA modification impacts the life of neural stem cells, and how it regulates histone modifications to maintain their self-renewal.
A comprehensive dataset of cancer cell metabolites has been compiled, showing consistent increases or decreases in certain metabolites across multiple tumor types. The study's findings offer insights into the metabolic programming between normal and cancer cells, with potential applications for novel therapies.